MolPort-001-684-488

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 16 USDMF, 1 CEP/COS, 2 EU WC, 9 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

10 API Suppliers

10 API Suppliers

FINISHED DOSAGE FORMULATIONS

84 FDF Dossiers, 54 FDA Orange Book, 3 Canada, 12 Australia, 3 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 1MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

5 SPI Pharma, 8 DKSH, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 5 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 24 Kerry, 3 Lonza Capsugel, 10 Microlex e.U, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 15 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 27 Direct Compression, 19 Thickeners and Stabilizers, 14 Co-Processed Excipients, 13 Granulation, 13 Lubricants & Glidants, 12 Coating Systems & Additives, 9 Taste Masking, 9 Disintegrants & Superdisintegrants, 8 Empty Capsules, 6 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 5 Film Formers & Plasticizers, 4 Topical, 4 Emulsifying Agents, 3 Coloring Agents, 3 Parenteral, 2 Solubilizers, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers